Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Aboyans V, Bjorck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB Eur Heart J 2018; 39(9): 35-41 ISSN 0195-668X Impact factor: 23,425
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Rother J, Sprynger Eur Heart J 2018; 39(9): 763-816 ISSN 0195-668X Impact factor: 23,425
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillation. Alhede C, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C Europace 2018; 20(1): 50-57 ISSN 1099-5129 Impact factor: 5,231
The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation. Alhede C, Lauridsen TK, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C Int J Cardiol 2018; 250: 122-127 ISSN 0167-5273 Impact factor: 4,034
Feasibility and clinical outcome of rotational atherectomy in patients presenting with an acute coronary syndrome. Allali A, Abdelghani M, Mankerious N, Abdel-Wahab M, Richardt G, Toelg R Catheter Cardiovasc Interv 2018; 00: 00 ISSN 1522-1946 Impact factor: n.n.e.
Feasibility and clinical outcome of rotational atherectomy in patients presenting with an acute coronary syndrome. Allali A, Abdelghani M, Mankerious N, Abdel-Wahab M, Richardt G, Toelg R Catheter Cardiovasc Interv 2018; 9: 27842-27852 ISSN 1522-1946 Impact factor: n.n.e.
Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID). Aziz M, Simonato M, Webb JG, Abdel-Wahab M, McElhinney D, Duncan A, Tchetche D, Barbanti M, Petronio AS, Maisano F, Ribeiro VG, Gaia DF, Rana R, Kocka V, Mathur M, Wijeysundera H, Hellig F, Nissen H, Catheter Cardiovasc Interv 2018; 92(6): 1163-1170 ISSN 1522-1946 Impact factor: n.n.e.
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Lancet 2018; 391(10137): 2335-2345 ISSN 0140-6736 Impact factor: 53,254
Temporal changes within mechanical dyssynchrony and rotational mechanics in Takotsubo syndrome: A cardiovascular magnetic resonance imaging study. Backhaus SJ, Stiermaier T, Lange T, Chiribiri A, Lamata P, Uhlig J, Kowallick JT, Raaz U, Villa A, Lotz J, Hasenfuss G, Thiele H, Eitel I, Schuster A Int J Cardiol 2018; 273: 256-262 ISSN 0167-5273 Impact factor: 4,034
Shock efficacy of single and dual coil electrodes-new insights from the NORDIC ICD Trial. Bansch D, Bonnemeier H, Brandt J, Bode F, Svendsen JH, Ritter O, Aring J, Gutleben KJ, Schneider R, Felk A, Hauser T, Buchholz A, Hindricks G, Wegscheider K Europace 2018; 20(6): 971-978 ISSN 1099-5129 Impact factor: 5,231
Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support. Becher PM, Schrage B, Sinning CR, Schmack B, Fluschnik N, Schwarzl M, Waldeyer C, Lindner D, Seiffert M, Neumann JT, Bernhardt AM, Zeymer U, Thiele H, Reichenspurner H, Blankenberg S, Twerenbold R, We Circulation 2018; 138(20): 2298-2300 ISSN 0009-7322 Impact factor: n.n.e.
Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials. Bennaghmouch N, de Veer AJWM, Bode K, Mahmoodi BK, Dewilde WJM, Lip GYH, Brueckmann M, Kleine E, Ten Berg JM Circulation 2018; 137(11): 1117-1129 ISSN 0009-7322 Impact factor: 18,881
Effects of Endurance Training on Detrimental Structural, Cellular, and Functional Alterations in Skeletal Muscles of Heart Failure With Preserved Ejection Fraction. Bowen TS, Herz C, Rolim NPL, Berre AO, Halle M, Kricke A, Linke A, da Silva GJ, Wisloff U, Adams V J Card Fail 2018; 24(9): 603-613 ISSN 1071-9164 Impact factor: 3,942
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope. Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martin A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG Eur Heart J 2018; 39(21): 43-80 ISSN 0195-668X Impact factor: 23,425
2018 ESC Guidelines for the diagnosis and management of syncope. Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martin A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG Eur Heart J 2018; 39(21): 1883-1948 ISSN 0195-668X Impact factor: 23,425
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Cosedis Nielsen J, Curtis AB, Davies DW, Day JD, d Avila A, Natasja d Europace 2018; 20(1): e1-160 ISSN 1099-5129 Impact factor: 5,231
2017-HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d Avila A, .... Europace 2018; 20(1): 157-208 ISSN 1099-5129 Impact factor: 5,231
Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and ISAR-DESIRE 4) trials. Colleran R, Joner M, Kufner S, Altevogt F, Neumann FJ, Abdel-Wahab M, Bohner J, Valina C, Richardt G, Zrenner B, Cassese S, Ibrahim T, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA Int J Cardiol 2018; 252: 57-62 ISSN 0167-5273 Impact factor: 4,034
Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions. Colleran R, Kufner S, Mehilli J, Rosenbeiger C, Schupke S, Hoppmann P, Joner M, Mankerious N, Fusaro M, Cassese S, Abdel-Wahab M, Neumann FJ, Richardt G, Ibrahim T, Schunkert H, Laugwitz KL, Kastrati J Am Coll Cardiol 2018; 71(18): 1973-1982 ISSN 0735-1097 Impact factor: 16,834
Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. Dan GA, Iliodromitis K, Scherr D, Marin F, Lenarczyk R, Estner HL, Kostkiewicz M, Dagres N, Lip GYH Europace 2018; 20(8): 1382-1387 ISSN 1099-5129 Impact factor: 5,231
Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy. De Bortoli M, Postma AV, Poloni G, Calore M, Minervini G, Mazzotti E, Rigato I, Ebert M, Lorenzon A, Vazza G, Cipriani A, Bariani R, Perazzolo Marra M, Husser D, Thiene G, Daliento L, Corrado D, Basso Circ Genom Precis Med 2018; 11(10): e002123 ISSN 2574-8300
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial. de Winter RJ, Katagiri Y, Asano T, Milewski KP, Lurz P, Buszman P, Jessurun GAJ, Koch KT, Troquay RPT, Hamer BJB, Ophuis TO, Wohrle J, Wyderka R, Cayla G, Hofma SH, Levesque S, Zurakowski A, Fischer D Lancet 2018; 391(10119): 431-440 ISSN 0140-6736 Impact factor: 53,254
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, Stellbrink C, Anker SD, Filippatos G, Gasparini M, Hindricks G, Blomstrom Lundqvist C, Ponikowski P, Ruschitzka F, Botto GL, Bulava Eur J Heart Fail 2018; 20(6): 1039-1051 ISSN 1388-9842 Impact factor: 10,683
Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-centre observations from a real-life population of patients. Dobrovie M, Spampinato RA, Efimova E, da Rocha E Silva JG, Fischer J, Kuehl M, Voigt JU, Belmans A, Ciarka A, Bonamigo Thome F, Schloma V, Dmitrieva Y, Lehmann S, Hahn J, Strotdrees E, Mohr FW, Garbad Eur J Cardiothorac Surg 2018; 53(6): 1144-1150 ISSN 1010-7940 Impact factor: 3,504
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D, Brachmann J, Darius H, Frey N, Katus HA, Rottbauer W, Schafer A, Thiele H, Bode C, Zeymer U Clin Res Cardiol 2018; 107(7): 533-538 ISSN 1861-0684 Impact factor: 4,455
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D, Brachmann J, Darius H, Frey N, Katus HA, Rottbauer W, Schafer A, Thiele H, Bode C, Zeymer U Clin Res Cardiol 2018; 107(7): 533-538 ISSN 1861-0684 Impact factor: 4,455
Updated Survey on Interventional Electrophysiology: 5-Year Follow-Up of Infrastructure, Procedures, and Training Positions in Germany. Eckardt L, Frommeyer G, Sommer P, Steven D, Deneke T, Estner HL, Kriatselis C, Kuniss M, Busch S, Tilz RR, Bonnemeier H, von Bary C, Voss F, Meyer C, Thomas D, Neuberger HR JACC Clin Electrophysiol 2018; 4(6): 820-827 ISSN 2405-500X
Cardiac magnetic resonance myocardial feature tracking for optimized prediction of cardiovascular events following myocardial infarction. Eitel I, Stiermaier T, Lange T, Rommel KP, Koschalka A, Kowallick JT, Lotz J, Kutty S, Hasenfu? G, Thiele H, Schuster A JACC Cardiovasc Imaging 2018; 11(10): 1433-1444 ISSN 1936-878X Impact factor: 10,247
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial. Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchetche D, Rovin JD, Buchbin JAMA 2018; 319(1): 27-37 ISSN 0098-7484 Impact factor: 47,661
Long-Term Prognosis of Patients With Takotsubo Syndrome. Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, M J Am Coll Cardiol 2018; 72(8): 874-882 ISSN 0735-1097 Impact factor: 16,834
Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. Hausleiter J, Braun D, Orban M, Latib A, Lurz P, Boekstegers P, von Bardeleben RS, Kowalski M, Hahn RT, Maisano F, Hagl C, Massberg S, Nabauer M EuroIntervention 2018; 14(6): 645-653 ISSN 1774-024X Impact factor: 4,417
Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment. Heidbuchel H, Dagres N, Antz M, Kuck KH, Lazure P, Murray S, Carrera C, Hindricks G, Vahanian A Europace 2018; 20(12): 1919-1928 ISSN 1099-5129 Impact factor: 5,231
Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Hernandez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Ro Europace 2018; 20(11): 1719-1753 ISSN 1099-5129 Impact factor: 5,231
Emergency medicine research results 2015/2016 in clinical practice. Hinkelbein J, Braunecker S, Neuhaus C, Drinhaus H, Bernhard M, Struck M, Bieler D, Trentzsch H, Thiele H, Singer D, B?ttiger BW Notfallmedizin Up2Date 2018; 13: 163-179 ISSN 1611-6550 Impact factor: n.n.e.
Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force. Ibanez B, Halvorsen S, Roffi M, Bueno H, Thiele H, Vranckx P, Neumann FJ, Windecker S, James S Eur Heart J 2018; 39(48): 4239-4242 ISSN 0195-668X Impact factor: 23,425
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhor Eur Heart J 2018; 39(2): 119-177 ISSN 0195-668X Impact factor: 23,425
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhor Kardiol Pol 2018; 76(2): 229-313 ISSN 0022-9032 Impact factor: 1,227
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study. Iung B, Delgado V, Lazure P, Murray S, Sirnes PA, Rosenhek R, Price S, Metra M, Carrera C, De Bonis M, Haude M, Hindricks G, Bax J, Vahanian A Eur Heart J 2018; 39(15): 1295-1303 ISSN 0195-668X Impact factor: 23,425
Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement. Jabbour RJ, Tanaka A, Finkelstein A, Mack M, Tamburino C, Van Mieghem N, de Backer O, Testa L, Gatto P, Purita P, Rahhab Z, Veulemans V, Stundl A, Barbanti M, Nerla R, Sinning JM, Dvir D, Tarantini G, J Am Coll Cardiol 2018; 71(14): 1513-1524 ISSN 0735-1097 Impact factor: 16,834
Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey. Jedrzejczyk-Patej E, Boveda S, Kalarus Z, Mazurek M, Goscinska-Bis K, Kiliszek M, Przybylski A, Potpara TS, Tilz R, Fumagalli S, Dagres N, Lenarczyk R Kardiol Pol 2018; 76(11): 1507-1515 ISSN 0022-9032 Impact factor: 1,213
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Kandzari DE, Bohm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K Lancet 2018; 391(10137): 2346-2355 ISSN 0140-6736 Impact factor: 53,254
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci?n Cardiaca y Electrofisiologia (SOLAECE). Katritsis DG, Boriani G, Cosio FG, Hindricks G, Jais P, Josephson ME, Keegan R, Kim YH, Knight BP, Kuck KH, Lane DA, Lip GYH, Malmborg H, Oral H, Pappone C, Themistoclakis S, Wood KA, Blomstrom-Lundqv Eur Heart J 2018; 39(16): 1442-1445 ISSN 0195-668X Impact factor: 23,425
Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study. Kebernik J, Borlich M, Tolg R, El-Mawardy M, Abdel-Wahab M, Richardt G Cardiol Ther 2018; 7(1): 79-87 ISSN 2193-6544
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve. Kim U, Blanke P, Windecker S, Kasel AM, Schafer U, Walters D, Linke A, Le Breton H, Schymik G, Spence MS, Sondergaard L, Abdel-Wahab M, Worthley S, Tchetche D, Reichenspurner H, Ohana M, Sellers SL, L EuroIntervention 2018; 14(5): e511-518 ISSN 1774-024X Impact factor: 4,417
The SAVI-TF Registry: 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 1,000 Patients. Kim WK, Hengstenberg C, Hilker M, Kerber S, Schafer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Zembala MO, Toggweiler S, Walther T, Mollmann H JACC Cardiovasc Interv 2018; 11(14): 1368-1374 ISSN 1936-8798 Impact factor: 9,881
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, Fetsch T, Van Gelder IC, Gentlesk P, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi HR, Massaro T, Mont L, Nielsen JC, Nolker G, Piccini Eur Heart J 2018; 39(32): 2942-2955 ISSN 0195-668X Impact factor: 23,425
Imaging Mass Spectrometry for Characterization of Atrial Fibrillation Subtypes. Klein O, Hanke T, Nebrich G, Yan J, Schubert B, Giavalisco P, Noack F, Thiele H, Mohamed SA Proteomics Clin Appl 2018; 12(6): e1700155 ISSN 1862-8346 Impact factor: 3,567
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castel Europace 2018; 20(3): 395-407 ISSN 1099-5129 Impact factor: 5,231
Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry. Kuhn C, Frerker C, Meyer AK, Kurz T, Schafer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck KH, Frey N, Frank D EuroIntervention 2018; 14(3): e301-305 ISSN 1774-024X Impact factor: 4,417
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial. Lansky A, Wijns W, Xu B, Kelbaek H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson Lancet 2018; 392(10153): 1117-1126 ISSN 0140-6736 Impact factor: 53,254
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial. Lansky A, Wijns W, Xu B, Kelbaek H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson Lancet 2018; 392(10153): 1117-1126 ISSN 0140-6736 Impact factor: n.n.e.
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. Lansky AJ, Messe SR, Brickman AM, Dwyer M, Bart van der Worp H, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Eur Heart J 2018; 39(19): 1687-1697 ISSN 0195-668X Impact factor: 23,425
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications. Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo MD, Sharif F, Wijns W, Tsioufis C, Mahfoud F EuroIntervention 2018; 14(5): e603-606 ISSN 1774-024X Impact factor: 4,417
Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL Trial. Lazar RM, Pavol MA, Bormann T, Dwyer MG, Kraemer C, White R, Zivadinov R, Wertheimer JC, Thone-Otto A, Ravdin LD, Naugle R, Mechanic-Hamilton D, Garmoe WS, Stringer AY, Bender HA, Kapadia SR, Kodali S JACC Cardiovasc Interv 2018; 11(4): 384-392 ISSN 1936-8798 Impact factor: 9,881
Prognostic Value and Determinants of CMR-Derived Left Atrial Function Assessed in STEMI. Ledwoch J, Stiermaier T, Fuernau G, de Waha S, Eitel C, Poss J, Desch S, Schuler G, Thiele H, Eitel I JACC Cardiovasc Imaging 2018; 11(1): 148-150 ISSN 1876-7591 Impact factor: 10,247
Cardiac Surgery Compared With Antibiotics Only in Patients Developing Infective Endocarditis After Transcatheter Aortic Valve Replacement. Mangner N, Leontyev S, Woitek FJ, Kiefer P, Haussig S, Binner C, Mende M, Schlotter F, Stachel G, Hollriegel R, Hommel J, Binner-Oussenek K, Misfeld M, Thiele H, Borger MA, Holzhey D, Linke A J Am Heart Assoc 2018; 7(17): e010027 ISSN 2047-9980 Impact factor: 4,45
Cardiac Surgery Compared With Antibiotics Only in Patients Developing Infective Endocarditis After Transcatheter Aortic Valve Replacement. Mangner N, Leontyev S, Woitek FJ, Kiefer P, Haussig S, Binner C, Mende M, Schlotter F, Stachel G, Hollriegel R, Hommel J, Binner-Oussenek K, Misfeld M, Thiele H, Borger MA, Holzhey D, Linke A J Am Heart Assoc 2018; 7(17): e010027 ISSN 2047-9980 Impact factor: 4,45
Predictors of Mortality and Symptomatic Outcome of Patients With Low-Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. Mangner N, Stachel G, Woitek F, Haussig S, Schlotter F, Hollriegel R, Adam J, Lindner A, Mohr FW, Schuler G, Kiefer P, Leontyev S, Borger MA, Thiele H, Holzhey D, Linke A J Am Heart Assoc 2018; 7(8): e007977 ISSN 2047-9980 Impact factor: 4,45
1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. Manoharan G, Van Mieghem NM, Windecker S, Bosmans J, Bleiziffer S, Modine T, Linke A, Scholtz W, Chevalier B, Gooley R, Zeng C, Oh JK, Grube E JACC Cardiovasc Interv 2018; 11(22): 2326-2334 ISSN 1936-8798 Impact factor: 10,247
Ventricular arrhythmias in patients with Takotsubo syndrome. Moller C, Eitel C, Thiele H, Eitel I, Stiermaier T J Arrhythm 2018; 34(4): 369-375 ISSN 1880-4276
Comprehensive assessment of sex hormones in Takotsubo syndrome. Moller C, Stiermaier T, Brabant G, Graf T, Thiele H, Eitel I Int J Cardiol 2018; 250: 11-15 ISSN 0167-5273 Impact factor: 4,034
Prevalence and long-term prognostic impact of malignancy in patients with Takotsubo syndrome. Moller C, Stiermaier T, Graf T, Eitel C, Thiele H, Burgdorf C, Eitel I Eur J Heart Fail 2018; 20(4): 816-818 ISSN 1388-9842 Impact factor: 10,683
Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. Mollmann H, Hengstenberg C, Hilker M, Kerber S, Schafer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Walther T, Zembala MO, Toggweiler S, Kim WK EuroIntervention 2018; 13(15): 1764-1770 ISSN 1774-024X Impact factor: 4,417
Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure. Orban M, Besler C, Braun D, Nabauer M, Zimmer M, Orban M, Noack T, Mehilli J, Hagl C, Seeburger J, Borger M, Linke A, Thiele H, Massberg S, Ender J, Lurz P, Hausleiter J Eur J Heart Fail 2018; 20(6): 1055-1062 ISSN 1388-9842 Impact factor: 10,683
Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure. Orban M, Besler C, Braun D, Nabauer M, Zimmer M, Orban M, Noack T, Mehilli J, Hagl C, Seeburger J, Borger M, Linke A, Thiele H, Massberg S, Ender J, Lurz P, Hausleiter J Eur J Heart Fail 2018; 20(6): 1055-1062 ISSN 1388-9842 Impact factor: n.n.e.
Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures. Pibarot P, Simonato M, Barbanti M, Linke A, Kornowski R, Rudolph T, Spence M, Moat N, Aldea G, Mennuni M, Iadanza A, Amrane H, Gaia D, Kim WK, Napodano M, Baumbach H, Finkelstein A, Kobayashi J, Breck JACC Cardiovasc Interv 2018; 11(2): 133-141 ISSN 1936-8798 Impact factor: 10,247
Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation. Polovina M, Hindricks G, Maggioni A, Piepoli M, Vardas P, Asanin M, Ethikic D, Ethuricic N, Milinkovic I, Seferovic PM Eur Heart J 2018; 39(45): 4030-4039 ISSN 0195-668X Impact factor: 23,425
Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. Puntmann VO, Valbuena S, Hinojar R, Petersen SE, Greenwood JP, Kramer CM, Kwong RY, McCann GP, Berry C, Nagel E J Cardiovasc Magn Reson 2018; 20(1): 67-72 ISSN 1097-6647 Impact factor: 5,457
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano Eur Heart J 2018; 39(34): 3165-3241 ISSN 0195-668X Impact factor: 23,425
Impact of Off-Hours Versus On-Hours Primary Percutaneous Coronary Intervention on Myocardial Damage and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction. Reinstadler SJ, Stiermaier T, Eitel C, Fuernau G, de Waha S, Feistritzer HJ, Saad M, Poss J, Desch S, Metzler B, Thiele H, Eitel I JACC Cardiovasc Interv 2018; 11(9): 915-917 ISSN 1936-8798 Impact factor: 9,881
Impact of Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction on Infarct Characteristics and Prognosis. Reinstadler SJ, Stiermaier T, Eitel C, Fuernau G, Saad M, Poss J, de Waha S, Mende M, Desch S, Metzler B, Thiele H, Eitel I Circ Cardiovasc Imaging 2018; 11(2): e006955 ISSN 1941-9651 Impact factor: 6,221
Prognostic Significance of Remote Myocardium Alterations Assessed by Quantitative Noncontrast T1 Mapping in ST-Segment Elevation Myocardial Infarction. Reinstadler SJ, Stiermaier T, Liebetrau J, Fuernau G, Eitel C, de Waha S, Desch S, Reil JC, Poss J, Metzler B, Lucke C, Gutberlet M, Schuler G, Thiele H, Eitel I JACC Cardiovasc Imaging 2018; 11(3): 411-419 ISSN 1876-7591 Impact factor: 10,247
Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Ribeiro HB, Rodes-Cabau J, Blanke P, Leipsic J, Kwan Park J, Bapat V, Makkar R, Simonato M, Barbanti M, Schofer J, Bleiziffer S, Latib A, Hildick-Smith D, Presbitero P, Windecker S, Napodano M, Cerill Eur Heart J 2018; 39(8): 687-695 ISSN 0195-668X Impact factor: 23,425
Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction. Saad M, Stiermaier T, Fuernau G, Poss J, Desch S, Thiele H, Eitel I Int J Cardiol 2018; 265: 251-255 ISSN 0167-5273 Impact factor: 4,034
Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction. Saad M, Stiermaier T, Fuernau G, Poss J, Desch S, Thiele H, Eitel I Int J Cardiol 2018; 265: 251-255 ISSN 0167-5273 Impact factor: n.n.e.
Impact of persistent ST elevation on outcome in patients with Takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry. Santoro F, Stiermaier T, Tarantino N, Guastafierro F, Graf T, Moller C, Di Martino LFM, Thiele H, Di Biase M, Eitel I, Brunetti ND Int J Cardiol 2018; 255: 140-144 ISSN 0167-5273 Impact factor: 4,034
ST-elevation magnitude and evolution in Takotsubo syndrome. Santoro F, Stiermaier T, Tarantino N, Guastafierro F, Graf T, Moller C, Di Martino LFM, Thiele H, Di Biase M, Eitel I, Brunetti ND Int J Cardiol 2018; 257: 39 ISSN 0167-5273 Impact factor: 4,034
Diagnostic criteria, left ventricular thrombosis, and QT-interval in Takotsubo syndrome. Santoro F, Stiermaier T, Tarantino N, Guastafierro F, Graf T, Moller C, Di Martino LFM, Thiele H, Di Biase M, Eitel I, Brunetti ND Int J Cardiol 2018; 258: 29 ISSN 0167-5273 Impact factor: 4,034
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S Cochrane Database Syst Rev 2018; 1: 9669-9672 ISSN 1361-6137 Impact factor: 6,754
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S Cochrane Database Syst Rev 2018; 1: 009669-009679 ISSN 1361-6137 Impact factor: n.n.e.
Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection. Seifert M, Moeller V, Arya A, Schau T, Hoelschermann F, Butter C Europace 2018; 20(5): 808-815 ISSN 1099-5129 Impact factor: 5,231
Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses. Seiffert M, Treede H, Schofer J, Linke A, Woehrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger EuroIntervention 2018; 14(4): 397-404 ISSN 1774-024X Impact factor: 4,417
Quantification of Aortic Valve Regurgitation by Pulsed Doppler Examination of the Left Subclavian Artery Velocity Contour: A Validation Study with Cardiovascular Magnetic Resonance Imaging. Spampinato RA, Jahnke C, Paetsch I, Hilbert S, Busch F, Schloma V, Dmitrieva Y, Bonamigo Thome F, Lobe S, Strotdrees E, Hindricks G, Mohr FW, Borger MA J Am Soc Echocardiogr 2018; 31(1): 42-51 ISSN 0894-7317 Impact factor: 6,827
Right ventricular strain assessment by cardiovascular magnetic resonance myocardial feature tracking allows optimized risk stratification in Takotsubo syndrome. Stiermaier T, Lange T, Chiribiri A, Moller C, Graf T, Raaz U, Villa A, Kowallick JT, Lotz J, Hasenfuss G, Thiele H, Schuster A, Eitel I PLoS One 2018; 13(8): e0202146 ISSN 1932-6203 Impact factor: 2,766
Right ventricular strain assessment by cardiovascular magnetic resonance myocardial feature tracking allows optimized risk stratification in Takotsubo syndrome. Stiermaier T, Lange T, Chiribiri A, Moller C, Graf T, Raaz U, Villa A, Kowallick JT, Lotz J, Hasenfuss G, Thiele H, Schuster A, Eitel I PLoS One 2018; 13(8): 0202146-0202152 ISSN 1932-6203 Impact factor: n.n.e.
Right ventricular strain assessment by cardiovascular magnetic resonance myocardial feature tracking allows optimized risk stratification in Takotsubo syndrome. Stiermaier T, Lange T, Chiribiri A, Moller C, Graf T, Raaz U, Villa A, Kowallick JT, Lotz J, Hasenfuss G, Thiele H, Schuster A, Eitel I PLoS One 2018; 13(8): 0202146-0202152 ISSN 1932-6203 Impact factor: n.n.e.
Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry. Stiermaier T, Santoro F, El-Battrawy I, Moller C, Graf T, Novo G, Santangelo A, Mariano E, Romeo F, Caldarola P, Fanelli M, Thiele H, Brunetti ND, Akin I, Eitel I Diabetes Care 2018; 41(5): 1084-1088 ISSN 0149-5992 Impact factor: 13,397
Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome. Stiermaier T, Santoro F, Graf T, Guastafierro F, Tarantino N, De Gennaro L, Caldarola P, Di Biase M, Thiele H, Brunetti ND, Moller C, Eitel I Clin Res Cardiol 2018; 107(7): 597-606 ISSN 1861-0684 Impact factor: 4,455
Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis. Toso E, Peyracchia M, Matta M, D Ascenzo F, Gaita F, Kornej J, Hindricks G, Jared Bunch T, Saliba W Int J Cardiol 2018; 270: 172-179 ISSN 0167-5273 Impact factor: 4,034
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Juni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN Eur Heart J 2018; 39(3): 213-260 ISSN 0195-668X Impact factor: 23,425
Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study. van Gils L, Wohrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Brecker S, Bapat V, Modine T, Soliman OI, Nersesov A, Allocco D, Falk V, Van Mieghem NM JACC Cardiovasc Interv 2018; 11(2): 119-128 ISSN 1936-8798 Impact factor: 10,247
The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial. Verma A, Ha ACT, Kirchhof P, Hindricks G, Healey JS, Hill MD, Sharma M, Wyse DG, Champagne J, Essebag V, Wells G, Gupta D, Heidbuchel H, Sanders P, Birnie DH Am Heart J 2018; 197: 124-132 ISSN 0002-8703 Impact factor: 4,171
2018 ESC/ESH Guidelines for the management of arterial hypertension. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz Eur Heart J 2018; 39(33): 3021-3104 ISSN 0195-668X Impact factor: 23,425
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, Engstrom T, Kaab S, Dambrink JH, Rioufol G, Toth GG, Piroth Z, Witt N, Frobert O, Kala P, Linke A, Jagic N, Mates M, Mavromatis N Engl J Med 2018; 379(3): 250-259 ISSN 0028-4793 Impact factor: 79,26
Safety and efficacy of persistent atrial fibrillation ablation using the second-generation cryoballoon. Yalin K, Abdin A, Lyan E, Sawan N, Liosis S, Elsner C, Jobs A, Bruggemann B, Koester J, Eitel I, Eitel C, Tilz RR Clin Res Cardiol 2018; 107(7): 570-577 ISSN 1861-0684 Impact factor: 4,455
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B N Engl J Med 2018; 379(14): 1332-1342 ISSN 0028-4793 Impact factor: 79,26
